About the Advanced Regenerative Manufacturing Institute
Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.
Manufacturing scalability, process and partnership.
There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.
Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.
ARMI’s Leadership Team
DEAN KAMEN
Executive Director & Chairman of the Board, ARMI
Maureen Toohey
Deputy Executive Director & Secretary of the Board
Thomas Bollenbach, Ph.D.
Chief Technology Officer
Jim Scott
Chief Administrative Officer
Jennifer MacDonald, M.D.
Chief Operating Officer
News Highlights
Events
Events
-
-
ARMI Investment Summit 2026
150 Dow Street 150 Dow Street, Manchester, NH, United StatesOver the course of a single day, the ARMI Investment Summit will connect founders, investors, commercialization experts, manufacturers, and industry leaders to accelerate innovation through expert panel discussions, the BioFab Startup Lab Pitch Competition, and meaningful networking opportunities.
-
2026 NHHA/FHC Annual Meeting
Omni Mount Washington Resort & SpaARMI COO Jennifer MacDonald, MD, will moderate a closing session on preparing New Hampshire health care providers for regenerative medicine at the 2026 NHHA/FHC Annual Meeting.
-
Bring Back the Trades Skills Expo – Massachusetts 2026
Best Western Trade Center, Marlborough, MassachusettsARMI | BioFabUSA will serve as a Community Champion at the 2026 Bring Back the Trades Skills Expo, helping students and adult learners explore career pathways in biomanufacturing and advanced manufacturing.
-
-
TERMIS-AM 2026
New Orleans, LouisianaARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
